MedTrace Logo

Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma

NCT01685606 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2022-03-04

Study results available
· View outcomes & findings →

Summary

The study of whether an infusion of blood cells called lymphocytes from a donor can stimulate the immune system to fight your leukemia/lymphoma.

Conditions

  • Mantle Cell Lymphoma
  • Diffuse Large Cell Lymphoma
  • Burkitts Lymphoma
  • T Cell Lymphomas
  • Acute Myeloid Leukemia/Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL

cellular immunotherapy

A minimum of 1x108 CD3+ cells and maximum of 2x108 CD3+ cells/kg from a haploidentical donor irrespective of the number of CD34+ cells will be infused.

Sponsors & Collaborators

  • Brown University

    lead OTHER

Principal Investigators

  • Peter Quesenberry, MD · Brown University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01685606 on ClinicalTrials.gov